UFIS-SWE-IG
0.1.0 - ci-build

UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions

Example Bundle: BuprenorSTADA-10perh-Transderm-SE-BS-MPD-BBDL

Buprenorphine STADA 10 mikrogram/timme depotplåster

MPID: SE-100000843-00052810
EURDID: 459

Full name: Buprenorphine STADA 10 mikrogram/timme depotplåster

- Scientific name part: Buprenorphine STADA

- Strength part: 10 mikrogram/timme

- Pharmaceutical dose form part: Depotplåster

Name usage: Swedish (Kingdom of Sweden)

Authorised dose form: Transdermal patch

Legal status of supply: Medicinal product subject to special medical prescription

Domain: Human use

Resource status: Current

Product classification:

  • 100000097250 buprenorphine

Marketing Authorisation 1 of 1

Authorisation number: 52810

Region: Kingdom of Sweden

Marketing authorisation holder: STADA Arzneimittel AG

Identifier:

  • LOC-100001022

Status: Valid (2016-06-30)

Package 1 of 2

PCID:

Description:
Påse, 12 x 1 plåster

Marketing status:

  • Kingdom of Sweden: Marketed

Pack size:

  • 12 Patch

Package: 1 Box (Cardboard)

Containing:

Package: 12 Sachet (PolyEthylene TerePhthalate)

Containing: 1 Patch

Manufactured Item

Dose form: Transdermal patch

Unit of presentation: Patch

Ingredient

Role: Active

Substance: Buprenorphine

Presentation strength: 10 microgram(s)/hour / 1 patch

Reference strength:
Buprenorphine 10 microgram(s)/hour / 1 patch

Package 2 of 2

PCID:

Description:
Påse, 4 x 1 plåster

Marketing status:

  • Kingdom of Sweden: Marketed

Pack size:

  • 4 Patch

Package: 1 Box (Cardboard)

Containing:

Package: 4 Sachet (PolyEthylene TerePhthalate)

Containing: 1 Patch

Manufactured Item

Dose form: Transdermal patch

Unit of presentation: Patch

Ingredient

Role: Active

Substance: Buprenorphine

Presentation strength: 10 microgram(s)/hour / 1 patch

Reference strength:
Buprenorphine 10 microgram(s)/hour / 1 patch

Administrable Product (1 of 1)

Dose form: Transdermal patch

Unit of presentation:

Route of administration:

  • Transdermal use

Ingredients:

Ingredient

Role: Active

Substance: Buprenorphine

Presentation strength: 10 microgram(s)/hour / 1 patch

Reference strength:
Buprenorphine 10 microgram(s)/hour / 1 patch